Skip to main content

Jessica Hagen

Jessica Hagen
By Jessica Hagen | 05:02 pm | March 13, 2026
During the HIMSS26 closing keynote, actor Jeremy Renner reflected on his recovery and the need for better care coordination and communication in healthcare.
By Jessica Hagen | 03:18 pm | March 12, 2026
During HIMSS26, attendees used astronaut medical emergency simulations to explore decision-making, resource allocation and value-based care strategies under extreme constraints.
By Jessica Hagen | 03:53 pm | March 11, 2026
At HIMSS26, Amazon One Medical announced the expanded release of Health AI that allows Amazon customers to utilize the chatbot for medical questions and connect with a One Medical provider, if needed.
By Jessica Hagen | 04:05 pm | March 10, 2026
At HIMSS26, keynote speaker and former president of Tesla Jon McNeill shared the framework Tesla used when first developing the car company and how those lessons can be used in healthcare.
By Jessica Hagen | 11:59 am | March 10, 2026
At HIMSS26, Verily Life Sciences announced a partnership with Samsung Electronics to combine Galaxy Watch8 with Verily's precision health platform to further clinical research.
By Jessica Hagen | 07:00 am | March 09, 2026
Cory Warner, Uber Health's global head of growth and operations, joined MobiHealthNews to discuss a new tool that lets health systems and payers set parameters for self-booked rides.
By Jessica Hagen | 01:28 pm | March 06, 2026
Dr. Dave Newman, chief medical officer of virtual care at Sanford Health, sat down with MobiHealthNews to discuss expanding virtual care and incorporating AI across the health system's largely rural footprint.
By Jessica Hagen | 11:16 am | March 06, 2026
The Helsinki‑based company offers AI-enabled biometric and gesture recognition technology that allows for device control with natural movements.
By Jessica Hagen | 04:52 pm | March 05, 2026
Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to restore vision in patients with macular degeneration.
By Jessica Hagen | 02:18 pm | March 05, 2026
The Massachusetts-based company will use the funds to advance its Spectris neurotechnology platform that uses visual and auditory stimulation to treat Alzheimer's disease.